sellModerate cluster of 2
Meredith Manning sold $229k of SLNO
Chief Commercial Officer at SOLENO THERAPEUTICS INC. 7,522 shares at an average of $30.44, traded Mar 27, 2026, filed Mar 31, 2026.
Warning score
41Value
$229k
7,522 shares
Holdings after
64,507
-10% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +13Trade size$229k at market
- +5Share of holdings soldSold 10% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001752631-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | SOpen-market sale Common Stock | -4,864 | $30.04 | $146k | 67,165 | Mar 31, 2026 |
| Mar 27, 2026 | SOpen-market sale Common Stock | -2,100 | $31.04 | $65k | 65,065 | Mar 31, 2026 |
| Mar 27, 2026 | SOpen-market sale Common Stock | -558 | $31.72 | $18k | 64,507 | Mar 31, 2026 |
Related signals
Other insiders at SOLENO THERAPEUTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | SOLENO THERAPEUTICS INC | Michael F. Huang Sr. VP of Clinical Development | $200k 6,582 shares | -14% | |
| 14Weak | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $317k 3,830 shares | -22% | |
| 0Weak | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $22k 266 shares | -2% | |
| 28Weak | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $265k 3,782 shares | -12% | |
| 70Notable | SOLENO THERAPEUTICS INC | Bhatnagar Anish CHIEF EXECUTIVE OFFICER | $47M 699,095 shares | -93% | |
| 40Moderate | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $11M 156,315 shares | -139% | |
| 50Moderate | SOLENO THERAPEUTICS INC | Michael F. Huang Sr. VP of Clinical Development | $1.0M 14,583 shares | -35% | |
| 58Moderate | SOLENO THERAPEUTICS INC | Bhatnagar Anish CHIEF EXECUTIVE OFFICER | $966k 21,091 shares | -3% | |
| 34Weak | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $139k 3,030 shares | -3% | |
| 55Moderate | SLNOsell SOLENO THERAPEUTICS INC | Bhatnagar Anish CHIEF EXECUTIVE OFFICER | $5.5M 115,004 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.